Cargando…
Genotype and phenotype in Parkinson's disease: Lessons in heterogeneity from deep brain stimulation
Variation in the genetic risk(s) of developing Parkinson's disease (PD) undoubtedly contributes to the subsequent phenotypic heterogeneity. Although patients with PD who undergo deep brain stimulation (DBS) are a skewed population, they represent a valuable resource for exploring the relationsh...
Autores principales: | Angeli, Aikaterina, Mencacci, Niccolo E, Duran, Raquel, Aviles-Olmos, Iciar, Kefalopoulou, Zinovia, Candelario, Joseph, Rusbridge, Sarah, Foley, Jennifer, Pradhan, Priyanka, Jahanshahi, Marjan, Zrinzo, Ludvic, Hariz, Marwan, Wood, Nicholas W, Hardy, John, Limousin, Patricia, Foltynie, Tom, MRCP, MD |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3886301/ https://www.ncbi.nlm.nih.gov/pubmed/23818421 http://dx.doi.org/10.1002/mds.25535 |
Ejemplares similares
-
Long-term outcome of subthalamic nucleus deep brain stimulation for Parkinson's disease using an MRI-guided and MRI-verified approach
por: Aviles-Olmos, Iciar, et al.
Publicado: (2014) -
Inhibitory Control on a Stop Signal Task in Tourette Syndrome before and after Deep Brain Stimulation of the Internal Segment of the Globus Pallidus
por: Morreale, Francesca, et al.
Publicado: (2021) -
Subthalamic nucleus deep brain stimulation induces impulsive action when patients with Parkinson’s disease act under speed pressure
por: Pote, Inês, et al.
Publicado: (2016) -
Understanding and Prevention of “Therapy-” Induced Dyskinesias
por: Aviles-Olmos, Iciar, et al.
Publicado: (2012) -
Critical Aspects of Clinical Trial Design for Novel Cell and Gene Therapies
por: Kefalopoulou, Zinovia, et al.
Publicado: (2011)